SCHEMBL23905307

SCHEMBL23905307

CCc1cc(OC)c2ncc(C(F)(F)F)cc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.41
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
TSHR P16473 1/20 0.36
HPGD P15428 3/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
PDE4B Q07343 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 2/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25114964 0.78 MAOB (0.45) RAB9ASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL26577804 0.78 PTGS2 (0.44) PTGS2RAB9AKMT2ANPSR1TP53
SCHEMBL23904742 0.77 PTGS2 (0.41) PTGS2ALDH1A1
SCHEMBL23905505 0.77 NOTUM (0.46) KDM4ELMNAMAPTCYP3A4ALDH1A1
SCHEMBL30007758 0.75 CA12 (0.44) PTGS2RAB9ATSHRMRGPRX4LMNA
SCHEMBL23195644 0.75 CA12 (0.44) PTGS2RAB9ATSHRMRGPRX4LMNA
SCHEMBL30339881 0.74 SMN1; SMN2 (0.44) SMN1; SMN2KDM4EKMT2ANPSR1TSHR
SCHEMBL20675605 0.70 MEN1 (0.49) PTGS2RAB9ASMN1; SMN2KDM4EMEN1
SCHEMBL22428631 0.70 AGBL2 (0.42) RAB9ASMN1; SMN2KDM4EKMT2ANPSR1
SCHEMBL24369007 0.70 KLKB1 (0.40) RAB9ASMN1; SMN2KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed